CVS Health Corp
$ 77.36
1.02%
21 Apr - close price
- Market Cap 99,144,917,000 USD
- Current Price $ 77.36
- High / Low $ 79.05 / 76.60
- Stock P/E 55.65
- Book Value 59.18
- EPS 1.39
- Next Earning Report 2026-05-06
- Dividend Per Share $2.66
- Dividend Yield 3.47 %
- Next Dividend Date 2026-05-04
- ROA 0.02 %
- ROE 0.02 %
- 52 Week High 84.46
- 52 Week Low 56.79
About
CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.
Analyst Target Price
$96.58
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-10 | 2025-10-29 | 2025-07-31 | 2025-05-01 | 2025-02-12 | 2024-11-06 | 2024-08-07 | 2024-05-01 | 2024-02-07 | 2023-11-01 | 2023-08-02 | 2023-05-03 |
| Reported EPS | 1.09 | 1.6 | 1.81 | 2.25 | 1.19 | 1.09 | 1.83 | 1.31 | 2.12 | 2.21 | 2.21 | 2.2 |
| Estimated EPS | 1 | 1.36 | 1.46 | 1.67 | 0.92 | 1.46 | 1.73 | 1.7 | 1.99 | 2.13 | 2.11 | 2.09 |
| Surprise | 0.09 | 0.24 | 0.35 | 0.58 | 0.27 | -0.37 | 0.1 | -0.39 | 0.13 | 0.08 | 0.1 | 0.11 |
| Surprise Percentage | 9% | 17.6471% | 23.9726% | 34.7305% | 29.3478% | -25.3425% | 5.7803% | -22.9412% | 6.5327% | 3.7559% | 4.7393% | 5.2632% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 2.21 |
| Currency | USD |
Previous Dividend Records
| May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-05-04 | 2026-02-02 | 2025-11-03 | 2025-08-01 | 2025-05-01 | 2025-02-03 | 2024-11-01 | 2024-08-01 | 2024-05-01 | 2024-02-01 |
| Amount | $0.665 | $0.665 | $0.665 | $0.665 | $0.665 | $0.665 | $0.665 | $0.665 | $0.665 | $0.665 |
Next Dividend Records
| Dividend per share (year): | $2.66 |
| Dividend Yield | 3.47% |
| Next Dividend Date | 2026-05-04 |
| Ex-Dividend Date | 2026-04-23 |
Recent News: CVS
2026-04-21 22:24:25
The Tennessee House passed a bill, the Fair RX Act, that would ban pharmacies from owning Pharmacy Benefits Managers (PBMs), sending it to Gov. Bill Lee's desk after it also passed in the Senate. CVS Health, which owns the PBM Caremark, has warned that if the bill becomes law, it will lead to the closure of all its Tennessee locations, including 25 MinuteClinic locations, and the loss of over 2,000 jobs, arguing the legislation will not lower drug costs and is solely designed to benefit independent pharmacies. Critics anticipate increased prescription costs and legal challenges, noting a similar ban in Arkansas was blocked by a federal court.
2026-04-21 17:10:33
UnitedHealth Group Inc. has identified "challenges" and "outstanding questions" regarding the U.S. Centers for Medicare and Medicaid Services' Medicare pilot program called Balance, which aims to cover obesity drugs. Despite these concerns, UnitedHealth will participate in a short-term demo phase that allows beneficiaries to access GLP-1 drugs at negotiated prices starting in July. Other major insurers like CVS Health, through its Aetna subsidiary, have opted not to participate in the full program, leading to a decline in shares for drugmakers Eli Lilly and Novo Nordisk.
2026-04-21 16:38:25
UnitedHealth Group exceeded analyst expectations for its first-quarter earnings, leading to a significant jump in its stock price and an increased full-year profit outlook for 2026. This positive development follows a challenging 2025 where the company, a Warren Buffett favorite, saw its stock decline by 34%. Analysts are now largely recommending the stock as a buy, citing the company's strong resources and efforts to right-size operations.
2026-04-21 16:11:00
Novo Nordisk (NVO) and Eli Lilly (LLY) saw their stock prices drop due to uncertainty surrounding a potential Medicare plan to cover GLP-1 weight loss drugs. Leading health insurers are reportedly undecided on whether to participate in the Trump administration's proposed coverage, causing investor concern for the obesity drugmakers.
2026-04-21 15:14:56
Eli Lilly and Co (LLY) stock dropped by 3.52% on April 21st, primarily due to CVS Health opting out of Medicare obesity drug coverage, which could limit market access for Lilly's treatments. Continued regulatory scrutiny around Foundayo, despite positive trial results, and existing concerns over stock valuation and market competition also contributed to the decline. Despite some positive developments like the acquisition of Kelonia Therapeutics, market access and regulatory uncertainty for its obesity franchise overshadowed these gains.
2026-04-21 14:23:28
CVS Pharmacy has introduced same-day delivery for over-the-counter cold and cough medications containing pseudoephedrine (PSE) or ephedrine (EPH) in 32 states. This service allows customers to purchase these products online and have them delivered, eliminating the need to visit a store when experiencing symptoms. To comply with federal and state regulations, an identity verification process via ID.me is required for these purchases, ensuring compliance with legal restrictions on these ingredients.
